✦ LIBER ✦

THE NATURAL HISTORY OF HEPATITIS C VIRUS INFECTION

✍ Scribed by Kenny-Walsh, Elizabeth

Book ID: 122840825
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 580 KB
Volume: 5
Category: Article
ISSN: 1089-3261
DOI: 10.1016/S1089-3261(05)70204-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The natural history of hepatitis C virus

The natural history of hepatitis C virus infection acquired during childhood

✍ Joan L. Robinson; Karen Doucette 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

The natural history of hepatitis C virus

The natural history of hepatitis C virus infection: D.L. Thomas, J. Astembroski, R.M. Rai, et al. JAMA 284:450–456, 2000

✍ Christopher Hillyer 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 239 KB

The clinical relevance of persistent rec

The clinical relevance of persistent recombinant immunoblot assay–indeterminate reactions: insights into the natural history of hepatitis C virus infection and implications for donor counseling

✍ Addisalem T. Makuria; Sukanya Raghuraman; Peter D. Burbelo; Cathy C. Cantilena; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 553 KB

The Changing Epidemiology and Natural Hi

The Changing Epidemiology and Natural History of Hepatitis C Virus Infection

✍ Bialek, Stephanie R.; Terrault, Norah A. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 299 KB

The natural history and outcome of liver

The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients

✍ Edward Gane 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB

Natural histories of hepatitis C virus i

Natural histories of hepatitis C virus infection in men and women simulated by the Markov model

✍ Junko Tanaka; Hiromitsu Kumada; Kenji Ikeda; Kazuaki Chayama; Masaaki Mizui; Kun 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB 👁 1 views

## Abstract The Markov model was introduced to simulate natural histories of hepatitis C virus (HCV) infection in men and women. The data set was constructed on 942 HCV carriers who were examined at least once a year without receiving antiviral therapies. Based on 2,251 patient‐year data, the proba